Drug Hunter Timeline
2015 - 2016
Proof of the principle 1st prototype developed, funded by EU ISF & the Estonian Ministry of Interior
Prototron has funded a handheld version of a drug tester for GHB analysis in saliva.
2017 - 2018
The technology was tested on-site (Weekend Baltic Festival) in cooperation with the Estonian Police. Funded IUT-3320.
2017 - 2020
The 2nd generation was developed, funded by EU Internal Security Fund & the Estonian Ministry of Interior.
2020 - 2021
Drug Hunter Analyzer under onsite testing in cooperation with Estonian Police. Funded by Estonian Research Council.
2021 - 2023
Artificial Intelligence (AI) development for Drug Hunter Analyzer and roadside validation in cooperation with Estonian Police. Funded by Estonian Research Council.
Get more info about EAG104.
2021 - 2023
Handheld drug meter development for GHB (gamma-Hydroxybutyric acid) also known as Liquid ecstasy, lollipops, liquid X, or liquid E
quantitative results in saliva and drinks. Funded by Estonian Research Council.
Get more info about MOBJD1015.
2022-2023
Development of SALIKIT for oral fluid sample treatment and drug analysis. Funded by Health Tech Estonia Accelerator through SmartCap’s Startup Estonia program (financed by the European Regional Development Fund within the framework of the EU60971 project)
2023 - ...
Pre-clinical study for illegal drugs analysis in oral fluid samples using SALIKIT&Drug Hunter. Funded under the European Innovation Ecosystems work programme of Horizon Europe, Women TechEU (project nr 101114520)enTechEU (nr 101114520)
2024
A new substance, Tramadol, is added to the expert system, fulfilling the requirements for ICH M10. Funded under the European Innovation Ecosystems work programme of Horizon Europe, Women TechEU (project nr 101114520)enTechEU (nr 101114520)
2023
In 2023, Drug Hunter achieved an amazing feat by receiving the Europol Excellence Award with the Estonian Police and Border Guard.
This recognition highlights their outstanding dedication and success in combatting drug-related crime.